MEA Exosome Research Products Market - Industry Trends And Forecast To 2030

Description

List of Tables

Middle East and Africa exosome research products market is projected to register a substantial CAGR of 29.5% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation:

Middle East and Africa Exosome Research Products Market, By Product (Instruments and Consumables), Indication (Cancer and Non-Cancer), Application (Therapeutics and Diagnosis), End Users (Hospitals, Clinical Testing Laboratories, Research Centers, Pharmaceutical and Biotechnology Company, Academic Institutes, and Others), Distribution Channel (Third Party Distributors, Online, Direct Tender, and Others), Country (South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Bahrain, Kuwait, Oman, Qatar, and Rest of Middle East and Africa) Industry Trends and Forecast to 2030

Market Drivers:

Growing prevalence of cancer, chronic inflammation, autoimmune disease, Lyme disease, and other chronic degenerative diseases

Increasing investments in pharmaceutical R&D and life sciences research

Market Players:

The key market players in Middle East and Africa exosome research products market are listed below:

Hologic Inc.

Luminex Corporation

Agilent Technologies, Inc.

QIAGEN

FUJIFILM Irvine Scientific( a subsidiary of FUJIFILM Holdings Corporation)

CUSABIO TECHNOLOGY LLC

NEXOSOME-ONCOLOGY

Norgen Biotek Corp.

Miltenyi Biotec

Beckman Coulter, Inc.

Hitachi, Ltd.

1 INTRODUCTION 53

1.1 OBJECTIVES OF THE STUDY 53
1.2 MARKET DEFINITION 53
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET 53
1.4 LIMITATIONS 55
1.5 MARKETS COVERED 55

2 MARKET SEGMENTATION 58

2.1 MARKETS COVERED 58
2.2 GEOGRAPHICAL SCOPE 59
2.3 YEARS CONSIDERED FOR THE STUDY 60
2.4 CURRENCY AND PRICING 60
2.5 DBMR TRIPOD DATA VALIDATION MODEL 61
2.6 MULTIVARIATE MODELLING 64
2.7 PRODUCT LIFELINE CURVE 65
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 66
2.9 DBMR MARKET POSITION GRID 67
2.10 MARKET APPLICATION COVERAGE GRID 69
2.11 VENDOR SHARE ANALYSIS 70
2.12 SECONDARY SOURCES 71
2.13 ASSUMPTIONS 71

3 EXECUTIVE SUMMARY 72

4 PREMIUM INSIGHTS 74

4.1 PESTEL ANALYSIS 75
4.2 PORTER'S FIVE FORCES MODEL 76
4.3 SUPPLY CHAIN ANALYSIS 77
4.4 VALUE CHAIN ANALYSIS 78
4.5 BUSINESS STRATEGY EXCELLENCE 79
4.6 CASE STUDIES 80
4.7 STRENGTH OF PRODUCT PORTFOLIO 82
4.8 TECHNOLOGICAL TRENDS 84
4.9 PRICING ANALYSIS 85

5 INDUSTRY INSIGHTS 86

6 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET, REGULATIONS 87

7 MARKET OVERVIEW 89

7.1 DRIVERS 91
- 7.1.1 GROWING PREVALENCE OF CANCER, CHRONIC INFLAMMATION, AUTOIMMUNE DISEASE, LYME DISEASE, AND OTHER CHRONIC DEGENERATIVE DISEASES 91
- 7.1.2 INCREASING INVESTMENTS IN PHARMACEUTICAL R&D AND LIFE SCIENCES RESEARCH 91
- 7.1.3 AVAILABILITY OF VARIOUS EXOSOME ISOLATION AND PURIFICATION TECHNIQUES AND PROGRESSING THERAPEUTIC VALUE OF EXOSOME 92
7.2 RESTRAINTS 93
- 7.2.1 LACK OF GOLD STANDARD PROTOCOLS FOR THE DEVELOPMENT AND PRODUCTION OF EXOSOMES 93
- 7.2.2 THE SHORTAGE OF SKILLED PROFESSIONALS REQUIRED FOR THE ISOLATION OF EXOSOME 93
7.3 OPPORTUNITIES 94
- 7.3.1 RISING DEMAND FOR SPECIALIZED TESTING SERVICES AMONG END USERS. 94
- 7.3.2 INCREASING ADVANCEMENT IN EXOSOME TECHNOLOGY 94
- 7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 95
7.4 CHALLENGES 96
- 7.4.1 SIDE EFFECTS ASSOCIATED WITH EXOSOME RESEARCH PRODUCTS 96
- 7.4.2 LATE APPROVAL ASSOCIATED WITH PRODUCT LAUNCHES 96

8 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT 97

8.1 OVERVIEW 98
8.2 CONSUMABLES 101
- 8.2.1 KITS AND REAGENTS 102
  - 8.2.1.1 EXOSOME BIOMARKER KITS 103
  - 8.2.1.2 EXOSOME ISOLATION KITS 103
  - 8.2.1.3 EXOSOME PURIFICATION KITS 103
  - 8.2.1.4 EXOSOME QUANTITATIVE KITS 103
  - 8.2.1.5 EXOSOME DETECTION KITS 103
  - 8.2.1.6 OTHERS 103
- 8.2.2 EXOSOME STANDARDS 103
- 8.2.3 EXOSOME ANTIBODIES 103
- 8.2.4 CELL LINES 103
- 8.2.5 IMMUNOPLATES 104
- 8.2.6 IMMUNOBEADS 104
- 8.2.7 BIOFLUIDS 104
- 8.2.8 OTHERS 104
8.3 INSTRUMENTS 104
- 8.3.1 BENCHTOP 105
- 8.3.2 STANDALONE 105

9 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION 106

9.1 OVERVIEW 107
9.2 CANCER 110
- 9.2.1 LUNG CANCER 111
- 9.2.2 BREAST CANCER 111
- 9.2.3 COLORECTAL CANCER 111
- 9.2.4 PROSTATE CANCER 112
- 9.2.5 OTHER CANCER 112
9.3 NON-CANCER 112
- 9.3.1 CARDIOVASCULAR DISEASE 113
- 9.3.2 NEURODEGENERATIVE DISEASE 113
- 9.3.3 INFECTIOUS DISEASE 113
- 9.3.4 OTHERS 113

10 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION 114

10.1 OVERVIEW 115
10.2 THERAPEUTICS 118
10.3 CONSUMABLES 119
10.4 INSTRUMENTS 119
10.5 DIAGNOSIS 119
10.6 CONSUMABLES 120
10.7 INSTRUMENTS 120

11 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 121

11.1 OVERVIEW 122
11.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY 125
11.3 CONSUMABLES 126
11.4 INSTRUMENTS 126
11.5 RESEARCH CENTRES 126
11.6 CONSUMABLES 127
11.7 INSTRUMENTS 127
11.8 ACADEMIC INSTITUTES 127
11.9 CONSUMABLES 128
11.10 INSTRUMENTS 128
11.11 CLINICAL TESTING LABORATORY 128
11.12 CONSUMABLES 129
11.13 INSTRUMENTS 129
11.14 HOSPITALS 130
11.15 CONSUMABLES 131
11.16 INSTRUMENTS 131
11.17 OTHERS 131

12 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL 132

12.1 OVERVIEW 133
12.2 THIRD PARTY DISTRIBUTORS 136
12.3 DIRECT SALES 136
12.4 ONLINE 137

13 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY REGION 138

13.1 MIDDLE EAST AND AFRICA 139
- 13.1.1 SOUTH AFRICA 149
- 13.1.2 EGYPT 155
- 13.1.3 SAUDI ARABIA 161
- 13.1.4 U.A.E 167
- 13.1.5 BAHARAIN 172
- 13.1.6 KUWAIT 178
- 13.1.7 OMAN 184
- 13.1.8 QATAR 190
- 13.1.9 MIDDLE EAST AND AFRICA 196

14 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET, COMPANY LANDSCAPE 197

14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 197

15 SWOT ANALYSIS 198

16 COMPANY PROFILE 199

16.1 THERMO FISHER SCIENTIFIC INC. 199
- 16.1.1 COMPANY SNAPSHOT 199
- 16.1.2 REVENUE ANALYSIS 199
- 16.1.3 COMPANY SHARE ANALYSIS 200
- 16.1.4 PRODUCT PORTFOLIO 200
- 16.1.5 RECENT DEVELOPMENT 201
16.2 EXODX (ACQUIRED BY BIO-TECHNE) 202
- 16.2.1 COMPANY SNAPSHOT 202
- 16.2.2 REVENUE ANALYSIS 202
- 16.2.3 COMPANY SHARE ANALYSIS 203
- 16.2.4 PRODUCT PORTFOLIO 203
- 16.2.5 RECENT DEVELOPMENT 203
16.3 MILTENYI BIOTEC 204
- 16.3.1 COMPANY SNAPSHOT 204
- 16.3.2 COMPANY SHARE ANALYSIS 204
- 16.3.3 PRODUCT PORTFOLIO 205
- 16.3.4 RECENT DEVELOPMENTS 205
16.4 LUMINEX CORPORATION 206
- 16.4.1 COMPANY SNAPSHOT 206
- 16.4.2 PRODUCT PORTFOLIO 206
- 16.4.3 RECENT DEVELOPMENT 206
16.5 HOLOGIC, INC. 207
- 16.5.1 COMPANY SNAPSHOT 207
- 16.5.2 REVENUE ANALYSIS 207
- 16.5.3 COMPANY SHARE ANALYSIS 208
- 16.5.4 PRODUCT PORTFOLIO 208
- 16.5.5 RECENT DEVELOPMENTS 208
16.6 AETHLON MEDICAL, INC. (2022) 209
- 16.6.1 COMPANY SNAPSHOT 209
- 16.6.2 PRODUCT PORTFOLIO 210
- 16.6.3 RECENT DEVELOPMENTS 210
16.7 AGILENT TECHNOLOGIES, INC. 211
- 16.7.1 COMPANY SNAPSHOT 211
- 16.7.2 REVENUE ANALYSIS 211
- 16.7.3 PRODUCT PORTFOLIO 212
- 16.7.4 RECENT DEVELOPMENT 212
16.8 AMSBI0 213
- 16.8.1 COMPANY SNAPSHOT 213
- 16.8.2 PRODUCT PORTFOLIO 213
- 16.8.3 RECENT DEVELOPMENT 213
16.9 AUDUBON BIOSCIENCE. 214
- 16.9.1 COMPANY SNAPSHOT 214
- 16.9.2 PRODUCT PORTFOLIO 214
- 16.9.3 RECENT DEVELOPMENT 214
16.10 BECKMAN COULTER, INC 215
- 16.10.1 COMPANY SNAPSHOT 215
- 16.10.2 PRODUCT PORTFOLIO 215
- 16.10.3 RECENT DEVELOPMENT 215
16.11 BIOVISION INC. (ACQUIRED BY ABCAM PLC) 216
- 16.11.1 COMPANY SNAPSHOT 216
- 16.11.2 REVENUE ANALYSIS 216
- 16.11.3 COMPANY SHARE ANALYSIS 217
- 16.11.4 PRODUCT PORTFOLIO 217
- 16.11.5 RECENT DEVELOPMENT 217
16.12 CELL GUIDANCE SYSTEMS LLC 218
- 16.12.1 COMPANY SNAPSHOT 218
- 16.12.2 PRODUCT PORTFOLIO 218
- 16.12.3 RECENT DEVELOPMENTS 218
16.13 CREATIVE BIOARRAY 219
- 16.13.1 COMPANY SNAPSHOT 219
- 16.13.2 PRODUCT PORTFOLIO 219
- 16.13.3 RECENT DEVELOPMENT 219
16.14 CUSABIO TECHNOLOGY LLC 220
- 16.14.1 COMPANY SNAPSHOT 220
- 16.14.2 PRODUCT PORTFOLIO 220
- 16.14.3 RECENT DEVELOPMENTS 220
16.15 FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION 221
- 16.15.1 COMPANY SNAPSHOT 221
- 16.15.2 REVENUE ANALYSIS 221
- 16.15.3 PRODUCT PORTFOLIO 222
- 16.15.4 RECENT DEVELOPMENT 222
16.16 HBMLS (ACQUIRED BY LONZA) 223
- 16.16.1 COMPANY SNAPSHOT 223
- 16.16.2 REVENUE ANALYSIS 223
- 16.16.3 PRODUCT PORTFOLIO 224
- 16.16.4 RECENT DEVELOPMENT 224
16.17 HITACHI, LTD. 225
- 16.17.1 COMPANY SNAPSHOT 225
- 16.17.2 REVENUE ANALYSIS 225
- 16.17.3 PRODUCT PORTFOLIO 226
- 16.17.4 RECENT DEVELOPMENT 226
16.18 INOVIQ 227
- 16.18.1 COMPANY SNAPSHOT 227
- 16.18.2 REVENUE ANALYSIS 227
- 16.18.3 PRODUCT PORTFOLIO 228
- 16.18.4 RECENT DEVELOPMENT 228
16.19 JSR MICRO NV 229
- 16.19.1 COMPANY SNAPSHOT 229
- 16.19.2 PRODUCT PORTFOLIO 229
- 16.19.3 RECENT DEVELOPMENT 229
16.20 MICROGENTAS 230
- 16.20.1 COMPANY SNAPSHOT 230
- 16.20.2 PRODUCT PORTFOLIO 230
- 16.20.3 RECENT DEVELOPMENTS 230
16.21 NANOSOMIX 231
- 16.21.1 COMPANY SNAPSHOT 231
- 16.21.2 PRODUCT PORTFOLIO 231
- 16.21.3 RECENT DEVELOPMENT 231
16.22 NEXOSOME-ONCOLOGY 232
- 16.22.1 COMPANY SNAPSHOT 232
- 16.22.2 PRODUCT PORTFOLIO 232
- 16.22.3 RECENT DEVELOPMENTS 232
16.23 NORGEN BIOTEK CORP. 233
- 16.23.1 COMPANY SNAPSHOT 233
- 16.23.2 PRODUCT PORTFOLIO 233
- 16.23.3 RECENT DEVELOPMENTS 233
16.24 NOVUS BIOLOGICALS 234
- 16.24.1 COMPANY SNAPSHOT 234
- 16.24.2 PRODUCT PORTFOLIO 234
- 16.24.3 RECENT DEVELOPMENT 235

16.25 PROTEOGENEX 236
- 16.25.1 COMPANY SNAPSHOT 236
- 16.25.2 PRODUCT PORTFOLIO 236
- 16.25.3 RECENT DEVELOPMENT 236
16.26 QIAGEN 237
- 16.26.1 COMPANY SNAPSHOT 237
- 16.26.2 REVENUE ANALYSIS 237
- 16.26.3 PRODUCT PORTFOLIO 238
- 16.26.4 RECENT DEVELOPMENT 238
16.27 ROOSTERBIO, INC. 239
- 16.27.1 COMPANY SNAPSHOT 239
- 16.27.2 PRODUCT PORTFOLIO 239
- 16.27.3 RECENT DEVELOPMENTS 240
16.28 SYSTEM BIOSCIENCES, LLC. 241
- 16.28.1 COMPANY SNAPSHOT 241
- 16.28.2 PRODUCT PORTFOLIO 241
- 16.28.3 RECENT DEVELOPMENT 241

17 QUESTIONNAIRE 242

18 RELATED REPORTS 245

LIST OF TABLES

TABLE 1 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET, PRICING ANALYSIS 55
TABLE 2 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT , 2021-2030 (USD THOUSAND) 70
TABLE 3 MIDDLE EAST & AFRICA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 71
TABLE 4 MIDDLE EAST & AFRICA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 72
TABLE 5 MIDDLE EAST & AFRICA KITS AND REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 72
TABLE 6 MIDDLE EAST & AFRICA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 75
TABLE 7 MIDDLE EAST & AFRICA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 75
TABLE 8 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 79
TABLE 9 MIDDLE EAST & AFRICA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 81
TABLE 10 MIDDLE EAST & AFRICA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 81
TABLE 11 MIDDLE EAST & AFRICA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 82
TABLE 12 MIDDLE EAST & AFRICA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 83
TABLE 13 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 87
TABLE 14 MIDDLE EAST & AFRICA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 88
TABLE 15 MIDDLE EAST & AFRICA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 88
TABLE 16 MIDDLE EAST & AFRICA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 89
TABLE 17 MIDDLE EAST & AFRICA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 90
TABLE 18 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 94
TABLE 19 MIDDLE EAST & AFRICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 95
TABLE 20 MIDDLE EAST & AFRICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND) 95
TABLE 21 MIDDLE EAST & AFRICA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 96
TABLE 22 MIDDLE EAST & AFRICA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND) 97
TABLE 23 MIDDLE EAST & AFRICA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 98
TABLE 24 MIDDLE EAST & AFRICA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND) 98
TABLE 25 MIDDLE EAST & AFRICA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 99
TABLE 26 MIDDLE EAST & AFRICA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 99
TABLE 27 MIDDLE EAST & AFRICA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 100
TABLE 28 MIDDLE EAST & AFRICA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND) 100
TABLE 29 MIDDLE EAST & AFRICA OTHERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 101
TABLE 30 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 105
TABLE 31 MIDDLE EAST & AFRICA THIRD PARTY DISTRIBUTORS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 106
TABLE 32 MIDDLE EAST & AFRICA DIRECT SALES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 107
TABLE 33 MIDDLE EAST & AFRICA ONLINE IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 107
TABLE 34 MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 113
TABLE 35 MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 113
TABLE 36 MIDDLE EAST AND AFRICA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 114
TABLE 37 MIDDLE EAST AND AFRICA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 114
TABLE 38 MIDDLE EAST AND AFRICA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 115
TABLE 39 MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 115
TABLE 40 MIDDLE EAST AND AFRICA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 115
TABLE 41 MIDDLE EAST AND AFRICA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 116
TABLE 42 MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 116
TABLE 43 MIDDLE EAST AND AFRICA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 116
TABLE 44 MIDDLE EAST AND AFRICA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 116
TABLE 45 MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 117
TABLE 46 MIDDLE EAST AND AFRICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 117
TABLE 47 MIDDLE EAST AND AFRICA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 117
TABLE 48 MIDDLE EAST AND AFRICA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 118
TABLE 49 MIDDLE EAST AND AFRICA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 118
TABLE 50 MIDDLE EAST AND AFRICA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 118
TABLE 51 MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 118
TABLE 52 SOUTH AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 119
TABLE 53 SOUTH AFRICA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 119
TABLE 54 SOUTH AFRICA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 120
TABLE 55 SOUTH AFRICA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 120
TABLE 56 SOUTH AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 120
TABLE 57 SOUTH AFRICA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 121
TABLE 58 SOUTH AFRICA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 121
TABLE 59 SOUTH AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 121
TABLE 60 SOUTH AFRICA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 122
TABLE 61 SOUTH AFRICA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 122
TABLE 62 SOUTH AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 122
TABLE 63 SOUTH AFRICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 123
TABLE 64 SOUTH AFRICA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 123
TABLE 65 SOUTH AFRICA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 123
TABLE 66 SOUTH AFRICA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 123
TABLE 67 SOUTH AFRICA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 124
TABLE 68 SOUTH AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 124
TABLE 69 EGYPT EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 125
TABLE 70 EGYPT CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 125
TABLE 71 EGYPT KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 126
TABLE 72 EGYPT INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 126
TABLE 73 EGYPT EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 126
TABLE 74 EGYPT CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 127
TABLE 75 EGYPT NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 127
TABLE 76 EGYPT EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 127
TABLE 77 EGYPT THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 128
TABLE 78 EGYPT DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 128
TABLE 79 EGYPT EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 128
TABLE 80 EGYPT PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 129
TABLE 81 EGYPT RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 129
TABLE 82 EGYPT ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 129
TABLE 83 EGYPT CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 129
TABLE 84 EGYPT HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 130
TABLE 85 EGYPT EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 130
TABLE 86 SAUDI ARABIA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 131
TABLE 87 SAUDI ARABIA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 131
TABLE 88 SAUDI ARABIA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 132
TABLE 89 SAUDI ARABIA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 132
TABLE 90 SAUDI ARABIA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 132
TABLE 91 SAUDI ARABIA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 133
TABLE 92 SAUDI ARABIA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 133
TABLE 93 SAUDI ARABIA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 133
TABLE 94 SAUDI ARABIA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 134
TABLE 95 SAUDI ARABIA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 134
TABLE 96 SAUDI ARABIA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 134
TABLE 97 SAUDI ARABIA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 135
TABLE 98 SAUDI ARABIA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 135
TABLE 99 SAUDI ARABIA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 135
TABLE 100 SAUDI ARABIA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 135
TABLE 101 SAUDI ARABIA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 136
TABLE 102 SAUDI ARABIA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 136
TABLE 103 U.A.E. EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 137
TABLE 104 U.A.E. CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 137
TABLE 105 U.A.E. KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 138
TABLE 106 U.A.E. INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 138
TABLE 107 U.A.E. CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 138
TABLE 108 U.A.E. NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 139
TABLE 109 U.A.E. EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 139
TABLE 110 U.A.E. THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 139
TABLE 111 U.A.E. DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 139
TABLE 112 U.A.E. EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 140
TABLE 113 U.A.E. PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 140
TABLE 114 U.A.E. RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 140
TABLE 115 U.A.E. ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 141
TABLE 116 U.A.E. CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 141
TABLE 117 U.A.E. HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 141
TABLE 118 U.A.E. EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 141
TABLE 119 BAHRAIN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 142
TABLE 120 BAHRAIN CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 142
TABLE 121 BAHRAIN KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 143
TABLE 122 BAHRAIN INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 143
TABLE 123 BAHRAIN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 143
TABLE 124 BAHRAIN CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 144
TABLE 125 BAHRAIN NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 144
TABLE 126 BAHRAIN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 144
TABLE 127 BAHRAIN THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 145
TABLE 128 BAHRAIN DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 145
TABLE 129 BAHRAIN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 145
TABLE 130 BAHRAIN PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 146
TABLE 131 BAHRAIN RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 146
TABLE 132 BAHRAIN ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 146
TABLE 133 BAHRAIN CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 146
TABLE 134 BAHRAIN HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 147
TABLE 135 BAHRAIN EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 147
TABLE 136 KUWAIT EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 148
TABLE 137 KUWAIT CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 148
TABLE 138 KUWAIT KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 149
TABLE 139 KUWAIT INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 149
TABLE 140 KUWAIT EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 149
TABLE 141 KUWAIT CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 150
TABLE 142 KUWAIT NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 150
TABLE 143 KUWAIT EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 150
TABLE 144 KUWAIT THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 151
TABLE 145 KUWAIT DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 151
TABLE 146 KUWAIT EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 151
TABLE 147 KUWAIT PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 152
TABLE 148 KUWAIT RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 152
TABLE 149 KUWAIT ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 152

LIST OF FIGURES

FIGURE 1 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: SEGMENTATION 27
FIGURE 2 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: DATA TRIANGULATION 30
FIGURE 3 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: DROC ANALYSIS 31
FIGURE 4 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS 32
FIGURE 5 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: COMPANY RESEARCH ANALYSIS 32
FIGURE 6 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: INTERVIEW DEMOGRAPHICS 35
FIGURE 7 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: DBMR MARKET POSITION GRID 36
FIGURE 8 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: MARKET APPLICATION COVERAGE GRID 38
FIGURE 9 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: VENDOR SHARE ANALYSIS 39
FIGURE 10 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: SEGMENTATION 42
FIGURE 11 THE INCREASE IN THE PREVALENCE OF CANCER AND OTHER AUTO-IMMUNE DISEASE IS EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET GROWTH IN THE FORECAST PERIOD 43
FIGURE 12 THE CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET IN 2023 & 2030 43
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET 59
FIGURE 14 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, 2022 67
FIGURE 15 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, 2023-2030 (USD THOUSAND) 68
FIGURE 16 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, CAGR (2023-2030) 68
FIGURE 17 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, LIFELINE CURVE 69
FIGURE 18 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, 2022 76
FIGURE 19 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, 2023-2030 (USD THOUSAND) 77
FIGURE 20 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, CAGR (2023-2030) 77
FIGURE 21 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, LIFELINE CURVE 78
FIGURE 22 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, 2022 84
FIGURE 23 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND) 85
FIGURE 24 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, CAGR (2023-2030) 85
FIGURE 25 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, LIFELINE CURVE 86
FIGURE 26 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, 2022 91
FIGURE 27 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, 2023-2030 (USD THOUSAND) 92
FIGURE 28 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, CAGR (2023-2030) 92
FIGURE 29 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, LIFELINE CURVE 93
FIGURE 30 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2022 102
FIGURE 31 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND) 103
FIGURE 32 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 103
FIGURE 33 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE 104
FIGURE 34 MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET: SNAPSHOT (2022) 109
FIGURE 35 MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022) 110
FIGURE 36 MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2023 & 2030) 110
FIGURE 37 MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022 & 2030) 111
FIGURE 38 MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET: PRODUCT (2023-2030) 111
FIGURE 39 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET: COMPANY SHARE 2022 (%) 166